טוען...
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?
Safety-tested modified vaccinia virus Ankara (MVA) has been established as a potent vector system for the development of candidate recombinant vaccines. The versatility of the vector system was recently demonstrated by the rapid production of experimental MVA vaccines for immunization against severe...
שמור ב:
| הוצא לאור ב: | Curr Opin Biotechnol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Ltd.
2004
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127071/ https://ncbi.nlm.nih.gov/pubmed/15560976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.copbio.2004.09.001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|